← Evidence map

ArticleGastroenterology & hepatology2006

Utility of the Nonabsorbed (<0.4%) Antibiotic Rifaximin in Gastroenterology and Hepatology.

Chinyu G Su et al.PubMed ↗Full text ↗

No numbers read from the abstract.

3 papers cite it

2006

2007

2008

2009

2010

2011

2012

2013

2014

2015

2016

2017

2018

2019

2020

2021

2022

2023

this papercites it

Utility of the Nonabsorbed (<0.4%) Antibiotic Rifaximin in Gastroenterology and Hepatology. | OpenQuestion